In Vitro Release of Interferon-Gamma from Peripheral Blood Lymphocytes in Cutaneous Adverse Drug Reactions

Figure 1

Division of study population. *It cannot be determined whether continuing the suspected drug is indeed responsible for the continuing clinical symptoms. **It cannot be determined whether the drug that was found negative in the test is indeed not responsible for the clinical symptoms.